跳至主要内容
临床试验/NCT04198311
NCT04198311Unknown不适用

The Impact of CBT for Insomnia on Substance Use Treatment Outcomes

University of Missouri-Columbia2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年8月26日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Recruitment

研究概览

简要总结

Project STAR aims to examine the feasibility, acceptability, and initial efficacy of a CBT-I supplement to outpatient alcohol and substance use treatment.

详细描述

Among those who receive treatment for alcohol use disorder (AUD), one in three relapses to problematic drinking within one year of treatment. Thus, additional treatment strategies are needed. Notably, up to 74% of individuals seeking treatment for AUD report co-occurring symptoms of insomnia, while 85% of those seeking SUD treatment report insomnia symptoms. Given the negative impact of insomnia on attention and emotion regulation, insomnia symptoms may decrease patients' abilities to attend to treatment for substance use and manage negative emotions that lead to craving and relapse. This project aims to examine the feasibility, acceptability, and initial efficacy of a CBT-I supplement to substance use treatment. Forty adults who meet diagnostic criteria for AUD or SUD and Insomnia Disorder will receive Cognitive Behavioral Therapy for Insomnia (CBT-I). In order to generate hypotheses regarding the efficacy of CBT-I for individuals who are and are not engaged in substance use treatment, we aim to recruit 20 participants who are engaged in substance use treatment through the community at baseline and 20 participants who are not. Outcomes will be assessed at the end of the active intervention period (6 weeks) and at 6 weeks post-intervention

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participation in alcohol or substance use treatment in the Columbia, MO area
  • DSM-5 criteria for moderate to severe Alcohol Use Disorder of Substance Use Disorder
  • DSM-5 episodic criterion (duration at least 1 month) for Insomnia Disorder

排除标准

  • unable to provide informed consent
  • cognitive impairment
  • continuous sobriety for 2+ months at baseline
  • untreated sleep disorder requiring more than behavioral treatment for insomnia
  • severe psychiatric disorder that requires immediate clinical attention
  • initiation of a sleep medication in the past six (6) weeks

结局指标

主要结局

Recruitment

时间窗: Assessed at Post-Treatment (week 6)

The number of participants who complete baseline.

Retention

时间窗: Assessed at Post-Treatment (week 6)

The number of participants who complete all treatment sessions

Treatment Satisfaction

时间窗: Assessed at Post-Treatment (week 6)

The satisfaction rating participants give the treatment.Assessed using the Client Satisfaction Questionnaire; The Client Satisfaction Questionnaire is an 8-item measure of satisfaction with treatment that has been validated in substance use treatment settings. Items are scores from 1 to 4, with higher scores indicating greater satisfaction with treatment.

次要结局

  • Insomnia severity(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Heavy-Drinking Days(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Substance Use Days(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Abstinence(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Alcohol or Other Drugs as Sleep Aids(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Sleep quality(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Dysfunctional beliefs(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Alcohol Problems(Change from baseline to post-treatment (week 6) to follow-up (week 12))
  • Total Wake Time(Change from baseline to post-treatment (week 6) to follow-up (week 12))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary E Miller

Professor, Psychiatry

University of Missouri-Columbia

研究点 (2)

Loading locations...

相似试验